Health & Biotech
Health Check: Medical device makers Trump drug developers in volatile US healthcare climate
Equity research firms see upside for medtech Compumedics
Big Freeze puts MND in focus – and the Aussie tech helping sufferers take back control
Health Check: Whether stoic or simply too poor, Australians spurn GP visits
Vital Signs Podcast: Breakthrough brain scanning technology overcoming diagnostic hurdles
ASX health May winners: Sector rises 1.59pc but market volatility remains
Biocurious: Nyrada looks to change the treatment landscape for brain and heart disorders
Recce secures full entitlement shortfall to complete $15.8m raise for phase III clinical trials
Health Check: Don’t dis-May! ASX biotechs record strong year-on-year share gains
Cardiex receives TGA approval for CONNEQT Pulse arterial health monitor
Lumos passes milestone in CLIA waiver study for point-of-care respiratory test
Dr Boreham’s Crucible: Even as it chills, can cryopreserver Vitrafy heat up?
Neurotech’s cannabinoid drug reports positive results from key study
Health Check: Stuck in biotech’s ‘death zone’, Opthea and Patrys check in on the sat phone
ReNerve boosts tissue-based products through partnership with Berkeley Biologics
Criterion: Healthscope’s collapse puts private hospitals in a world of pain
Scott Power: ASX health stocks rise as Healthscope landlord agrees to rent deferral deal
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
